Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
35.0%
% of XPH's 40 holdings also in FTXH
28.0%
% of FTXH's 51 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.8% | 7.4% | 4.8% |
|
PFIZER INC | 4.6% | 7.3% | 4.6% |
|
JOHNSON & JOHNSON | 4.5% | 6.9% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 7.4% | 4.4% |
|
ELI LILLY & CO | 4.8% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to FTXH
|
CATALENT INC | 4.7% |
|
AXSOME THERAPEUTICS, INC. | 4.6% |
|
ROYALTY PHARMA PLC CLASS A | 4.5% |
|
INTRA-CELLULAR THERAPIES INC | 4.2% |
|
ELANCO ANIMAL HEALTH, INC. | 3.6% |
|
CORCEPT THERAPEUTICS INC | 3.6% |
 |
PERRIGO CO | 3.3% |
|
ARVINAS, INC. | 2.4% |
|
PSIVIDA CORP | 2.2% |
|
AMPHASTAR PHARMACEUTICALS INC | 2.1% |
XPH Underweight Relative to FTXH
|
ABBVIE INC | -7.1% |
|
AMGEN INC | -3.6% |
|
CARDINAL HEALTH INC | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
VERTEX PHARMACEUTICALS INC | -3.5% |
|
GILEAD SCIENCES INC | -3.5% |
|
BIOGEN IDEC INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -2.9% |
|
PFIZER INC | -2.8% |